For Labcorp's employer drug testing services, should we prioritize faster turnaround times or more comprehensive substance panels?

Introduction

The trade-off we're examining today is whether Labcorp's employer drug testing services should prioritize faster turnaround times or more comprehensive substance panels. This decision is crucial for balancing client needs, regulatory compliance, and operational efficiency. I'll analyze this trade-off by considering stakeholder impacts, metrics, experimentation, and decision frameworks.

Step 1

Clarifying Questions (3 minutes)

• Context: I'm assuming this is for pre-employment screening, but could you clarify if this also applies to ongoing employee testing or specific industries? This impacts our prioritization based on client needs and regulatory requirements.

• Business Context: Based on the competitive landscape, I'm thinking faster turnaround might be a key differentiator. How does our current turnaround time compare to competitors, and what's the revenue impact of speed vs. comprehensiveness?

• User Impact: Considering both employers and job candidates, I'm curious about the pain points in the current process. Can you share any feedback on whether delays or false negatives are a bigger concern for our clients?

• Technical Feasibility: I'm wondering about our lab capacity and technology. Is our current bottleneck in sample processing or analysis? This would help determine if faster turnaround is technically feasible without major investment.

• Resource Allocation: Thinking about our team structure, are our lab technicians cross-trained for various tests, or do we have specialists? This affects how we might reallocate resources for either faster processing or more comprehensive panels.